SEARCH
検索詳細鈴木 諒太 (スズキ リヨウタ)
| 北海道大学病院 小児・周産・女性科 | 助教 |
研究者基本情報
■ 学位■ URL
researchmap URLホームページURL■ ID 各種
研究者番号
- 31018659
研究分野
経歴
■ 経歴経歴
- 2026年04月 - 現在
北海道大学, 大学院医学研究院 生殖・発達医学分野 小児科学教室, 助教, 日本国 - 2025年04月 - 2026年03月
北海道大学, 大学院医学研究院 生殖・発達医学分野 小児科学教室, 医員, 日本国 - 2021年04月 - 2025年03月
北海道大学, 大学院医学研究科, 学生, 日本国 - 2020年10月 - 2021年03月
日鋼記念病院, 小児科, 医員, 日本国 - 2020年04月 - 2020年09月
函館中央病院, 小児科, 医員, 日本国 - 2018年04月 - 2020年03月
日鋼記念病院, 小児科, 医員, 日本国 - 2017年04月 - 2018年03月
釧路赤十字病院, 小児科, 医員, 日本国 - 2016年04月 - 2017年03月
KKR札幌医療センター, 小児科, 医員, 日本国 - 2014年04月 - 2016年03月
恵み野病院, 初期研修医, 日本国 - 2008年04月 - 2014年03月
宮崎大学, 医学部 医学科, 学生, 日本国
研究活動情報
■ 受賞- 2024年06月, 日本小児腎臓病学会, 森田賞
Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease
鈴木諒太
- Investigation of clinical and genetic characteristics of Alport syndrome using a national registry in Japan (JP-ALPS).
Okuda Y; Mikami N; Hamada R; Hataya H; Tanaka K; Terano C; Fujita N; Miura K; Ishizuka K; Shirai Y; Kamei K; Ogura M; Okamoto T; Suzuki R; Shinozuka S; Shima Y; Oka M; Shimabukuro W; Tsukaguchi H; Inagaki T; Nishiyama K; Hashimoto T; Ito N; Yamamura T; Horinouchi T; Ishikura K; Nakanishi K; Nozu K
Clinical and experimental nephrology, 2025年09月19日
研究論文(学術雑誌),Background
Comprehensive epidemiological information regarding Alport syndrome, particularly from national cohorts, is limited.Methods
Utilizing a national Alport syndrome cohort in Japan established in October 2022, we analyzed clinical characteristics according to genotype. Only baseline data collected retrospectively at enrollment were used. We present longitudinal trends in estimated glomerular filtration rate (eGFR) and urine protein-to-creatinine ratio.Results
Of the 121 patients included, 105 (86.8%) underwent genetic testing and 82 (67.8%) had a kidney biopsy. Among those with genetic testing, 77 (73.3%) had X-linked Alport syndrome. Kidney function was normal at disease onset, with a median eGFR of 112.9 (interquartile range, 99.3-131.1) mL/min/1.73 m2. Although a steep decline during adolescence was observed in some male patients with X-linked Alport syndrome, eGFR decline was relatively slow during childhood and adolescence; the point estimate of eGFR at age 20 was 88.6 mL/min/1.73 m2. Six patients transitioned to end-stage kidney disease during the follow-up period. Eighty-one patients (66.9%) used renin-angiotensin system (RAS) inhibitors, and the rate of eGFR decline was slower after RAS inhibitor initiation. Notably, the median ages at onset and diagnosis were 3.0 and 5.1 years, respectively, because Japan's widespread urinalysis screening program for 3-year-old children enables initiation of early treatment.Conclusions
In our cohort, which consisted mainly of patients who did not require kidney replacement therapy in childhood and adolescence, kidney function was preserved throughout this period except for some male patients with X-linked Alport syndrome. RAS inhibitor use may be associated with a reduced rate of eGFR decline. - 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
横川 涼介; 山本 朝日; 鈴木 諒太; 高橋 俊行; 林 麻子; 佐藤 泰征; 岡本 孝之
日本腎臓学会誌, 67, 4, 572, 572, (一社)日本腎臓学会, 2025年06月
日本語 - Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome
Ryota Suzuki; Nana Sakakibara; Sae Murakami; Yuta Ichikawa; Hideaki Kitakado; Chika Ueda; Yu Tanaka; Eri Okada; Atsushi Kondo; Yuya Aoto; Shinya Ishiko; Shingo Ishimori; China Nagano; Tomohiko Yamamura; Tomoko Horinouchi; Takayuki Okamoto; Kandai Nozu
Nephrology Dialysis Transplantation, 2025年04月01日
研究論文(学術雑誌) - Comprehensive Splice Pattern Analysis for Previously Reported <i>OCRL</i> Splicing Variants and Their Phenotypic Contributions.
Rossanti R; Okada E; Sakakibara N; Suzuki R; Inoki Y; Ichikawa Y; Tanaka Y; Kitakado H; Ueda C; Kondo A; Aoto Y; Nagano C; Horinouchi T; Yamamura T; Ishimori S; Nozu K
Kidney international reports, 10, 5, 1509, 1517, 2025年03月03日, [国際誌]
英語, 研究論文(学術雑誌),Introduction
Two distinct phenotypes of Dent disease-2 and Lowe syndrome are caused by oculocerebrorenal syndrome of Lowe (OCRL) abnormality. Previous genetic studies demonstrated that truncating variants in exons 1 to 7 results in Dent disease-2 and in exons 8 to 24, result in Lowe syndrome. Recently, we successfully identified a functional OCRL isoform, whose altered initiation codons (Met187 and Met206) in exon 8 can affect the OCRL-truncating variant phenotypes. However, the association between OCRL splicing variants and phenotypes is poorly understood.Methods
We performed a detailed splicing pattern analysis of previously reported 28 OCRL splicing variants obtained from the Human Gene Mutation Database. We assessed the variant consequences at the mRNA level using an in vitro splicing assay with a minigene system, and examined their compatibility with in silico algorithms and correlation with disease phenotypes.Results
Aberrant splicing was confirmed in all 27 variants, except for 1, in which splicing could not be experimentally confirmed in the minigene system, and therefore could not be concluded with certainty. Splicing variants in OCRL exons 1 to 7 resulted in Dent disease-2, and in exons 9 to 24 resulted in Lowe syndrome. In 1 case, c.561-2 A > G in exon 8 demonstrated Dent disease-2.Conclusion
This study provides significant data on the pathogenicity of OCRL splicing variants and genotype-phenotype correlations. In c.561-2 A > G, the latter altered initiation codon of the OCRL isoform (Met206) was preserved, potentially indicating the Dent disease-2 phenotype. This result supports our recent finding regarding the altered initiation codons in exon 8 of the OCRL isoform. - Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis.
Inoue S; Atsushi Kondo; Inoki Y; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Suzuki R; Okada E; Sakakibara N; Horinouchi T; Nozu K
Clinical and experimental nephrology, 2024年06月14日
研究論文(学術雑誌),Background
Wilms tumor 1 (WT1; NM_024426) causes Denys-Drash syndrome, Frasier syndrome, or isolated focal segmental glomerulosclerosis. Several WT1 intron variants are pathogenic; however, the pathogenicity of some variants remains undefined. Whether a candidate variant detected in a patient is pathogenic is very important for determining the therapeutic options for the patient.Methods
In this study, we evaluated the pathogenicity of WT1 gene intron variants with undetermined pathogenicity by comparing their splicing patterns with those of the wild-type using an in vitro splicing assay using minigenes. The three variants registered as likely disease-causing genes: Mut1 (c.1017-9 T > C(IVS5)), Mut2 (c.1355-28C > T(IVS8)), Mut3 (c.1447 + 1G > C(IVS9)), were included as subjects along the 34 splicing variants registered in the Human Gene Mutation Database (HGMD)®.Results
The results showed no significant differences in splicing patterns between Mut1 or Mut2 and the wild-type; however, significant differences were observed in Mut3.Conclusion
We concluded that Mut1 and Mut2 do not possess pathogenicity although they were registered as likely pathogenic, whereas Mut3 exhibits pathogenicity. Our results suggest that the pathogenicity of intronic variants detected in patients should be carefully evaluated. - Systematic Review of Clinical Characteristics and Genotype-Phenotype Correlation in LAMB2-Associated Disease.
Suzuki R; Sakakibara N; Ichikawa Y; Kitakado H; Ueda C; Tanaka Y; Okada E; Kondo A; Ishiko S; Ishimori S; Nagano C; Yamamura T; Horinouchi T; Okamoto T; Nozu K
Kidney international reports, 2023年07月04日
研究論文(学術雑誌),Introduction
Laminin subunit beta-2 (LAMB2)-associated disease, termed Pierson syndrome, presents with congenital nephrotic syndrome, ocular symptoms, and neuromuscular symptoms. In recent years, however, the widespread use of next-generation sequencing (NGS) has helped to discover a variety of phenotypes associated with this disease. Therefore, we conducted this systematic review.Methods
A literature search of patients with LAMB2 variants was conducted, and 110 patients were investigated, including 12 of our patients. For genotype-phenotype correlation analyses, the extracted data were investigated for pathogenic variant types, the severity of nephropathy, and extrarenal symptoms. Survival analyses were also performed for the onset age of end-stage kidney disease (ESKD).Results
Among all patients, 81 (78%) presented with congenital nephrotic syndrome, and 52 (55%) developed ESKD within 12 months. The median age at ESKD onset was 6.0 months. Kidney survival analysis showed that patients with biallelic truncating variants had a significantly earlier progression to ESKD than those with other variants (median age 1.2 months vs. 60.0 months, P < 0.05). Although the laminin N-terminal domain is functionally important in laminin proteins, and variants in the laminin N-terminal domain are said to result in a severe kidney phenotype such as earlier onset age and worse prognosis, there were no significant differences in onset age of nephropathy and progression to ESKD between patients with nontruncating variants located in the laminin N-terminal domain and those with variants located outside this domain.Conclusion
This study revealed a diversity of LAMB2-associated diseases, characteristics of LAMB2 nephropathy, and genotype-phenotype correlations. - Association of Familial Fanconi Syndrome with a Novel GATM Variant.
Kudo H; Suzuki R; Kondo A; Nozu K; Nakamura Y; Mikami H; Soma J; Nakaya I
The Tohoku journal of experimental medicine, 2023年06月08日
研究論文(学術雑誌) - All reported non-canonical splice site variants in GLA cause aberrant splicing.
Eri Okada; Horinouchi T; Yamamura T; Aoto Y; Suzuki R; Ichikawa Y; Tanaka Y; Masuda C; Kitakado H; Kondo A; Sakakibara N; Ishiko S; Nagano C; Ishimori S; Usui J; Yamagata K; Matsuo M; Nozu K
Clinical and experimental nephrology, 2023年05月31日
研究論文(学術雑誌),Background
Fabry disease is an X-linked lysosomal storage disorder caused by insufficient α-galactosidase A (GLA) activity resulting from variants in the GLA gene, which leads to glycosphingolipid accumulation and life-threatening, multi-organ complications. Approximately 50 variants have been reported that cause splicing abnormalities in GLA. Most were found within canonical splice sites, which are highly conserved GT and AG splice acceptor and donor dinucleotides, whereas one-third were located outside canonical splice sites, making it difficult to interpret their pathogenicity. In this study, we aimed to investigate the genetic pathogenicity of variants located in non-canonical splice sites within the GLA gene.Methods
13 variants, including four deep intronic variants, were selected from the Human Gene Variant Database Professional. We performed an in vitro splicing assay to identify splicing abnormalities in the variants.Results
All candidate non-canonical splice site variants in GLA caused aberrant splicing. Additionally, all but one variant was protein-truncating. The four deep intronic variants generated abnormal transcripts, including a cryptic exon, as well as normal transcripts, with the proportion of each differing in a cell-specific manner.Conclusions
Validation of splicing effects using an in vitro splicing assay is useful for confirming pathogenicity and determining associations with clinical phenotypes. - Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study.
Yasuhiro Ueda; Takayuki Okamoto; Yasuyuki Sato; Asako Hayashi; Toshiyuki Takahashi; Ryota Suzuki; Aoyagi H; MICHIHIKO UENO; Kobayashi N; Uetake K; Nakanishi M; Ariga T; Atsushi Manabe
Pediatric nephrology (Berlin, Germany), 2023年04月13日
研究論文(学術雑誌),Background
Glucocorticoids affect bone turnover. Little is known about how bone turnover changes when glucocorticoids are discontinued following long-term administration.Methods
This retrospective observational study was conducted on the relationship between discontinuation of long-term administration of glucocorticoid and bone turnover markers (BTMs) in patients with childhood-onset idiopathic nephrotic syndrome. Serum bone alkaline phosphatase (BAP), intact procollagen type 1 N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase-5b (TRACP-5b) were evaluated as BTMs.Results
Thirty-eight pairs of BTMs at glucocorticoid administration and after discontinuation were analyzed in 29 patients. The median age at baseline was 12.4 (interquartile range, 9.0-14.5) years, and the median time from the onset of nephrotic syndrome was 5.9 (3.3-9.7) years. The mean period from prednisolone discontinuation to the measurement of BTMs after glucocorticoid discontinuation was 3.5 ± 1.0 months. Changes in BTMs after glucocorticoid discontinuation were modest when the daily prednisolone dose was < 0.25 mg/kg/day (ln BAP standard deviation [SD] score, p = 0.19; log intact P1NP SD score, p = 0.70; TRACP-5b, p = 0.95). When the daily prednisolone dose was ≥ 0.25 mg/kg/day, all BTMs increased significantly after glucocorticoid discontinuation (ln BAP SD score, p < 0.01; log intact P1NP SD score, p < 0.01; TRACP-5b, p < 0.01).Conclusions
Decreased BTMs can rise within a few months of discontinuing long-term glucocorticoid administration. When the administered glucocorticoid dose is low, changes in BTMs may be small. A higher resolution version of the Graphical abstract is available as Supplementary information. - Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene.
Eri Okada; Aoto Y; Horinouchi T; Yamamura T; Ichikawa Y; Tanaka Y; Ueda C; Kitakado H; Kondo A; Sakakibara N; Suzuki R; Usui J; Yamagata K; Iijima K; Nozu K
Clinical and experimental nephrology, 2022年11月12日
研究論文(学術雑誌),Background and objectives
The evident genotype-phenotype correlation shown by the X-linked Alport syndrome warrants the assessment of the impact of identified gene variants on aberrant splicing. We previously reported that single nucleotide variants (SNVs) in the last nucleotide of exons in COL4A5 cause aberrant splicing. It is known that the nucleotides located 2nd and 3rd to the last nucleotides of exons can also play an essential role in the first step of the splicing process. In this study, we aimed to investigate whether SNVs positioned 2nd or 3rd to the last nucleotide of exons in COL4A5 resulted in aberrant splicing.Methods
We selected eight candidate variants: six from the Human Gene Variant Database Professional and two from our cohort. We performed an in-vitro splicing assay and reverse transcription-polymerase chain reaction (RT-PCR) for messenger RNA obtained from patients, if available.Results
The candidate variants were initially classified into the following groups: three nonsense, two missense, and three synonymous variants. Splicing assays and RT-PCR for messenger RNA revealed that six of the eight variants caused aberrant splicing. Four variants, initially classified as non-truncating variants, were found to be truncating ones, which usually show relatively more severe phenotypes.Conclusion
We revealed that exonic SNVs positioned 2nd or 3rd to the last nucleotide of exons in the COL4A5 were responsible for aberrant splicing. The results of our study suggest that attention should be paid when interpreting the pathogenicity of exonic SNVs near the 5' splice site. - CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.
Hayashi A; Takayuki Okamoto; Nio-Kobayashi J; Iwahara N; Suzuki R; Ueda Y; Takahashi T; Yasuyuki Sato; Iwanaga T; Hotta K
Biomedical research (Tokyo, Japan), 2022年10月01日
研究論文(学術雑誌), Long-term calcineurin inhibitor (CNI) administration causes irreversible nephrotoxicity. Therefore, early CNI-induced nephrotoxicity detection is necessary for patients who will need long-term CNI administration. There is no pathological indicator for early CNI-induced nephrotoxicity. Here, serial protocol kidney biopsy specimens from five kidney-transplant patients with severe CNI-induced nephrotoxicity were examined. We observed that the increase in CD44 expression in glomerular parietal epithelial cells (PECs) preceded the chronic pathological changes of CNI-induced nephrotoxicity such as tubular atrophy/interstitial fibrosis, arterial hyaline thickening, and focal segmental glomerulosclerosis (FSGS). This result suggests that CD44-positive PECs have pivotal roles in FSGS development in human CNI-induced nephrotoxicity as well as rodent models. CD44 could be useful as a pathological marker for early CNI-induced nephrotoxicity detection post kidney transplantation. - Cooccurrence of Alport syndrome and poststreptococcal acute glomerulonephritis with improvement after steroid administration
Ryota Suzuki; Asako Hayashi; Megumi Endo; Yasuhiro Ueda; Toshiyuki Takahashi; Yasuyuki Sato; Takayuki Okamoto
CEN Case Reports, 2022年04月10日
研究論文(学術雑誌) - Outbreak of aseptic meningitis caused by echovirus 30 in Kushiro, Japan in 2017.
Ryota Suzuki
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2019年05月06日
研究論文(学術雑誌),Background
Echovirus 30 (E30) is one of the most common causative agents for aseptic meningitis.Objectives
In the autumn of 2017, there was an outbreak caused by E30 in Kushiro, Hokkaido, Japan. The aim of this study was to characterize this outbreak.Study design
Fifty-nine patients were admitted to the Department of Pediatrics, Kushiro Red Cross Hospital (KRCH) with clinical diagnosis of aseptic meningitis. Among those, 36 patients were finally diagnosed as E30-associated aseptic meningitis by the detection of viral RNA using reverse transcription-polymerase chain reaction (RT-PCR) and/or the evidence of more than four-fold rise in neutralizing antibody (NA) titers in the convalescent phase relative to those in the acute phase. We investigated these 36 confirmed cases.Results
The median age was 6 years (range: 6 months-14 years). The positive signs and symptoms were as follows: fever (100%), headache (94%), vomiting (92%), jolt accentuation (77%), neck stiffness (74%), Kernig sign (29%), and abdominal pain (28%). The median cerebrospinal fluid (CSF) white cell count, neutrophil count, and lymphocyte count were 222/μL (range: 3-1434/μL), 144/μL (range: 1-1269/μL), and 85/μL (range: 2-354/μL), respectively. Although the detected viral genes demonstrated same cluster, they were different from E30 strains observed in Japan between 2010 and 2014.Conclusion
We mainly showed clinical and virological features of the E30-associated aseptic meningitis outbreak that occurred in Kushiro. To prevent further spread of E30 infection, continuous surveillance of enterovirus (EV) circulation and standard precautions are considered essential.
- 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
横川 涼介; 山本 朝日; 鈴木 諒太; 高橋 俊行; 林 麻子; 佐藤 泰征; 岡本 孝之, 日本腎臓学会誌, 67, 4, 572, 572, 2025年06月
(一社)日本腎臓学会, 日本語 - 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
横川 涼介; 山本 朝日; 鈴木 諒太; 高橋 俊行; 林 麻子; 佐藤 泰征; 岡本 孝之, 日本小児腎臓病学会雑誌, 38, Suppl., 116, 116, 2025年05月
(一社)日本小児腎臓病学会, 日本語 - 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
横川涼介; 山本朝日; 鈴木諒太; 高橋俊行; 林麻子; 佐藤泰征; 岡本孝之, 日本腎臓学会誌(Web), 67, 4, 2025年 - 小児難治性ネフローゼ症候群に対するリツキシマブ定期反復投与後の長期成績
横川涼介; 山本朝日; 鈴木諒太; 高橋俊行; 林麻子; 林麻子; 佐藤泰征; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 38, 2025年 - 繰り返す尿路感染症によってループスアンチコアグラント陽性一過性APTT延長が遷延した男児例
横川涼介; 山本朝日; 鈴木諒太; 平林真介; 岩原直也; 広瀬貴行; 堀田記世彦; 安本篤史; 岡本孝之; 真部淳, 日本小児科学会雑誌, 129, 2, 2025年 - AVPR2ヘテロ接合性バリアントを持つ女性における,X染色体不活性化パターンと腎性尿崩症の発症との相関
鈴木 諒太; 岡本 孝之; 大塚 泰史; 岡 政史; 西川 有希; 亀田 啓; 高橋 由華; 武者 育麻; 野津 寛大, 日本小児腎臓病学会雑誌, 37, 23, 23, 2024年
(一社)日本小児腎臓病学会, 日本語 - 経口デスモプレシン製剤の緩徐な導入により,安全性を確保した上で症状の改善を得た部分型X連鎖性腎性尿崩症の5歳男児例
山本朝日; 鈴木諒太; 横川涼介; 林麻子; 林麻子; 佐藤泰征; 伊藤ゆたか; 八鍬聡; 野津寛大; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 37, 2024年 - OCRL異常症の表現型は,phosphatidylinositol4,5-bisphosphate5-phosphatase活性と相関する
鈴木諒太; 鈴木諒太; 榊原菜々; 市川裕太; 北角英晶; 上田知佳; 田中悠; 近藤淳; 長野智那; 堀之内智子; 岡本孝之; 野津寛大, 日本小児腎臓病学会雑誌(Web), 37, 2024年 - OCRL異常症の表現型は,phosphatidylinositol4,5-bisphosphate5-phosphatase活性と相関する
鈴木諒太; 榊原菜々; 市川裕太; 北角英晶; 上田知佳; 田中悠; 岡田絵里; 近藤淳; 長野智那; 堀之内智子; 岡本孝之; 野津寛大, 日本腎臓学会誌(Web), 66, 4, 2024年 - X染色体連鎖型Alport症候群女性における、X染色体不活化パターン・表現型相関
鈴木 諒太; 榊原 菜々; 市川 裕太; 北角 英晶; 上田 知佳; 田中 悠; 岡田 絵里; 近藤 淳; 石森 真吾; 堀之内 智子; 岡本 孝之; 野津 寛大, 日本小児腎臓病学会雑誌, 36, Suppl., 96, 96, 2023年05月
(一社)日本小児腎臓病学会, 日本語 - LAMB2関連疾患における臨床的特徴と遺伝型・表現型相関
鈴木 諒太; 榊原 菜々; 市川 裕太; 北角 英晶; 上田 知佳; 田中 悠; 岡田 絵里; 近藤 淳; 石森 真吾; 堀之内 智子; 岡本 孝之; 野津 寛大, 日本小児腎臓病学会雑誌, 36, Suppl., 96, 96, 2023年05月
(一社)日本小児腎臓病学会, 日本語 - 本邦における1型/2型Bartter症候群の臨床的特徴とGenotype/Phenotype Correlation
近藤 淳; 市川 裕太; 田中 悠; 上田 知佳; 北角 英晶; 鈴木 諒太; 岡田 絵里; 青砥 悠哉; 榊原 菜々; 堀之内 智子; 野津 寛大, 日本小児腎臓病学会雑誌, 36, Suppl., 115, 115, 2023年05月
(一社)日本小児腎臓病学会, 日本語 - Podocalyxin異常に伴うポドサイトパチーの3例
北角 英晶; 榊原 菜々; 市川 裕太; 田中 悠; 上田 知佳; 近藤 淳; 鈴木 諒太; 岡田 絵里; 堀之内 智子; 藤丸 季可; 前田 亮; 稲熊 大城, 日本小児腎臓病学会雑誌, 36, Suppl., 132, 132, 2023年05月
(一社)日本小児腎臓病学会, 日本語 - In vitro splicing解析によるWT1遺伝子におけるIntron variantの病原性評価
井上 誠也; 近藤 淳; 市川 裕太; 田中 悠; 上田 知佳; 北角 英晶; 鈴木 諒太; 岡田 絵里; 榊原 菜々; 堀之内 智子; 野津 寛大, 日本小児腎臓病学会雑誌, 36, Suppl., 134, 134, 2023年05月
(一社)日本小児腎臓病学会, 日本語 - CUBN異常症の遺伝学的特徴と臨床像
榊原 菜々; 市川 裕太; 田中 悠; 鈴木 諒太; 北角 英晶; 上田 知佳; 近藤 淳; 岡田 絵里; 堀之内 智子; 野津 寛大, 日本腎臓学会誌, 65, 3, 260, 260, 2023年05月
(一社)日本腎臓学会, 日本語 - Podocalyxin異常に伴う腎炎発症機序の検討
北角 英晶; 榊原 菜々; 市川 裕太; 田中 悠; 上田 知佳; 近藤 淳; 鈴木 諒太; 岡田 絵里; 堀之内 智子; 藤丸 季可; 前田 亮; 稲熊 大城; 野津 寛大, 日本腎臓学会誌, 65, 3, 261, 261, 2023年05月
(一社)日本腎臓学会, 日本語 - 緩徐進行性Fanconi症候群家系におけるGATM遺伝子新規ミスセンス変異の同定
工藤 宏紀; 中屋 来哉; 中村 祐貴; 鈴木 諒太; 近藤 淳; 野津 寛大; 三上 仁; 相馬 淳, 日本腎臓学会誌, 65, 3, 262, 262, 2023年05月
(一社)日本腎臓学会, 日本語 - COL4A5遺伝子のイントロン+3から+5のバリアントにおける病原性の有無の検討
北角 英晶; 青砥 悠哉; 市川 裕太; 田中 悠; 鈴木 諒太; 増田 知佳; 近藤 淳; 岡田 絵里; 榊原 菜々; 堀之内 智子; 野津 寛大, 日本小児科学会雑誌, 127, 2, 251, 251, 2023年02月
(公社)日本小児科学会, 日本語 - CUBN異常症の遺伝学的特徴と臨床像
榊原菜々; 市川裕太; 田中悠; 鈴木諒太; 北角英晶; 上田知佳; 近藤淳; 岡田絵里; 堀之内智子; 野津寛大, 日本腎臓学会誌(Web), 65, 3, 2023年 - 膿胸と急性腎障害を合併した常染色体顕性アルポート症候群+特発性ネフローゼ症候群の1例
林 麻子; 佐藤 泰征; 上田 泰弘; 鈴木 諒太; 武藤 潤; 加賀 基知三; 加藤 達哉; 榊原 菜々; 野津 寛大; 岡本 孝之, 日本小児腎臓病学会雑誌, 36, 20, 20, 2023年
(一社)日本小児腎臓病学会, 日本語 - 本邦における1型/2型Bartter症候群の臨床的特徴とGenotype/Phenotype Correlation
近藤淳; 市川裕太; 田中悠; 上田知佳; 北角英晶; 鈴木諒太; 鈴木諒太; 岡田絵里; 岡田絵里; 青砥悠哉; 青砥悠哉; 榊原菜々; 堀之内智子; 野津寛大, 日本小児腎臓病学会雑誌(Web), 36, 2023年 - In vitro splicing解析によるWT1遺伝子におけるIntron variantの病原性評価
井上誠也; 近藤淳; 市川裕太; 田中悠; 上田知佳; 北角英晶; 鈴木諒太; 鈴木諒太; 岡田絵里; 岡田絵里; 榊原菜々; 堀之内智子; 野津寛大, 日本小児腎臓病学会雑誌(Web), 36, 2023年 - タクロリムス内服中に慢性副鼻腔炎の治療としてマクロライド少量長期投与療法を導入した生体腎移植後例
横川涼介; 鈴木諒太; 山口敦史; 福田篤; 佐藤泰征; 岩原直也; 広瀬貴行; 堀田記世彦; 岡本孝之, 日本小児腎不全学会学術集会プログラム・抄録集, 44th, 2023年 - 膿胸と急性腎障害を合併した常染色体顕性アルポート症候群+特発性ネフローゼ症候群の1例
林麻子; 佐藤泰征; 上田泰弘; 鈴木諒太; 武藤潤; 加賀基知三; 加藤達哉; 榊原菜々; 野津寛大; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 36, 2023年 - Genetics in CKD Topics X染色体の不活化と遺伝性腎疾患
鈴木諒太; 鈴木諒太; 野津寛大, 腎と透析, 94, 3, 2023年 - AVPR2ヘテロ接合体バリアントを持つ女性における,X染色体不活性化パターンと腎性尿崩症の発症との相関
鈴木諒太; 鈴木諒太; 岡田絵里; 榊原菜々; 大塚泰史; 岡政史; 西川有希; 亀田啓; 高橋由華; 武者育麻; 石森真吾; 市川裕太; 北角英晶; 田中悠; 近藤淳; 堀之内智子; 岡本孝之; 野津寛大, 日本小児科学会雑誌, 127, 2, 2023年 - LAMB2関連疾患における臨床的特徴と遺伝型・表現型相関
鈴木諒太; 鈴木諒太; 榊原菜々; 市川裕太; 北角英晶; 上田知佳; 田中悠; 岡田絵里; 近藤淳; 石森真吾; 石森真吾; 堀之内智子; 岡本孝之; 野津寛大, 日本小児腎臓病学会雑誌(Web), 36, 2023年 - X染色体連鎖型Alport症候群女性における,X染色体不活化パターン・表現型相関
鈴木諒太; 鈴木諒太; 榊原菜々; 市川裕太; 北角英晶; 上田知佳; 田中悠; 岡田絵里; 岡田絵里; 近藤淳; 石森真吾; 石森真吾; 堀之内智子; 岡本孝之; 野津寛大, 日本小児腎臓病学会雑誌(Web), 36, 2023年 - X染色体連鎖型Alport症候群女性における,X染色体不活化・表現型相関
鈴木諒太; 榊原菜々; 市川裕太; 北角英晶; 上田知佳; 田中悠; 岡田絵里; 近藤淳; 石森真吾; 堀之内智子; 岡本孝之; 野津寛大, 日本腎臓学会誌(Web), 65, 3, 2023年 - 腎移植後CNI腎症を早期に検出する組織学的指標としての壁側上皮細胞へのCD44発現の有用性
林 麻子; 鈴木 諒太; 上田 泰弘; 高橋 俊行; 佐藤 泰征; 岡本 孝之, 日本腎臓学会誌, 64, 3, 232, 232, 2022年05月
(一社)日本腎臓学会, 日本語 - 小児特発性ネフローゼ症候群におけるステロイド投与と骨代謝マーカーの経時的変化に関する検討
上田 泰弘; 高橋 俊行; 鈴木 諒太; 林 麻子; 佐藤 泰征; 岡本 孝之, 日本腎臓学会誌, 64, 3, 314, 314, 2022年05月
(一社)日本腎臓学会, 日本語 - 小児特発性ネフローゼ症候群におけるステロイド投与と骨代謝マーカーの経時的変化に関する検討
上田 泰弘; 高橋 俊行; 鈴木 諒太; 林 麻子; 佐藤 泰征; 岡本 孝之, 日本小児腎臓病学会雑誌, 35, 1Suppl., 118, 118, 2022年04月
(一社)日本小児腎臓病学会, 日本語 - 腎移植後CNI腎症を早期に検出する組織学的指標としての壁側上皮細胞へのCD44発現の有用性
林 麻子; 鈴木 諒太; 上田 泰弘; 高橋 俊行; 佐藤 泰征; 岩原 直也; 辻 隆裕; 堀田 記世彦; 岡本 孝之, 日本小児腎臓病学会雑誌, 35, 1Suppl., 145, 145, 2022年04月
(一社)日本小児腎臓病学会, 日本語 - Mycobacterium massilienseによる腹膜透析関連腹膜炎,腹腔内・腹壁膿瘍治療後に腎移植を行った1例
上田泰弘; 岡本孝之; 佐藤泰征; 高橋俊行; 鈴木諒太; 林麻子; 真部淳, 日本小児科学会雑誌, 126, 2, 2022年 - 腎移植後CNI腎症を早期に検出する組織学的指標としての壁側上皮細胞へのCD44発現の有用性
林麻子; 鈴木諒太; 上田泰弘; 高橋俊行; 佐藤泰征; 岡本孝之, 日本腎臓学会誌(Web), 64, 3, 2022年 - 小児特発性ネフローゼ症候群におけるステロイド投与と骨代謝マーカーの経時的変化に関する検討
上田泰弘; 高橋俊行; 鈴木諒太; 林麻子; 佐藤泰征; 岡本孝之, 日本腎臓学会誌(Web), 64, 3, 2022年 - 腎移植後CNI腎症を早期に検出する組織学的指標としての壁側上皮細胞へのCD44発現の有用性
林麻子; 鈴木諒太; 上田泰弘; 高橋俊行; 佐藤泰征; 岩原直也; 辻隆裕; 堀田記世彦; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 35, 1, 2022年 - 小児特発性ネフローゼ症候群におけるステロイド投与と骨代謝マーカーの経時的変化に関する検討
上田泰弘; 高橋俊行; 鈴木諒太; 林麻子; 佐藤泰征; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 35, 1, 2022年 - 高血圧緊急症による著明な心筋肥厚を合併する患児に対し,厳格な降圧管理により腎移植を施行し得た1例
佐藤泰征; 鈴木諒太; 上田泰弘; 高橋俊行; 林麻子; 堀田記世彦; 岡本孝之, 日本小児腎不全学会学術集会プログラム・抄録集, 43rd, 2022年 - 溶連菌感染後急性糸球体腎炎を合併したアルポート症候群
鈴木諒太; 遠藤愛; 上田泰弘; 林麻子; 佐藤泰征; 岡本孝之, 日本小児腎臓病学会雑誌(Web), 35, 1, 2022年 - Mycobacteroides massilienseによる腹膜透析関連腹膜炎および腹腔内・腹壁膿瘍治療後に腎移植を行った1例
上田泰弘; 高橋俊行; 鈴木諒太; 林麻子; 佐藤泰征; 岡本孝之, 日本腎臓学会誌(Web), 63, 6-E, 2021年 - ITGA3遺伝子変異に伴うネフローゼ症候群の腎病理
小川弥生; 岡本孝之; 林麻子; 高橋俊行; 鈴木諒太; 上田康弘; 佐藤泰征; 康徳東; 柳内充, 日本臨床分子形態学会総会・学術集会講演プログラム・要旨集, 53rd, 2021年 - 胎児期に臍帯嚢胞を認め、胎児MRIで尿膜管遺残と診断した1例
兼次 洋介; 丸尾 優爾; 鈴木 諒太; 高橋 美智; 加藤 晶; 鳴神 雅史; 寺下 友佳代; 鈴木 靖人; 仲西 正憲; 米原 利栄; 山田 崇弘; 森川 守; 本多 昌平; 守屋 仁彦, 日本小児科学会雑誌, 121, 11, 1893, 1893, 2017年11月
(公社)日本小児科学会, 日本語
■ 所属学協会
